跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Profile

Matthew Miller

MM

Matthew Miller

McMaster University, Canada

Dr. Miller is Executive Director of Global Nexus, and Scientific Director of the M.G. DeGroote Institute for Infectious Disease Research at McMaster University. He is a Professor in the Department of Biochemistry and Biomedical Sciences and was awarded the honorific title of University Scholar in 2025. He also serves as Co-Director of Canadian Pandemic Preparedness Hub (CP2H). Dr. Miller holds the Canada Research Chair in Viral Pandemics. He has received several major awards and distinctions including election to the Royal Society of Canada College of New Scholars in 2024. Dr. Miller’s research program is focused primarily on pandemic prevention, especially the development of broadly-protective vaccines, antibodies, and therapeutics. He is a member of several national advisory bodies and is co-founder and Chief Scientific Officer of AeroImmune Inc.